Page 27 - IMCJ April 2020

Table 1. Summary of baseline characteristics: count (percentage) for discrete variables and mean (sd) for continuous
ones

Overall By Treatment
Variable (n = 92) Probiotic (n = 46) Placebo (n = 46) P Value
male gender 18 (20%) 10 (22%) 8 (17%) .79
age (year) 49.4 (10.4%) 50.1 (10.1%) 48.6 (10.8%) .51
triglyceride (mg/dl) 206.6 (58.4%) 214.0 (67.9%) 199.1 (46.5%) .22

Figure 1. Trajectory of triglyceride level

trial that has been conducted using spore forming Bacilli Previous studies have demonstrated that the use of
probiotic in participants with mild to moderate HT with 30 day short term spore forming bacilli probiotic altered
successful lowering of blood triglyceride levels. The dietary endotoxemia in human subjects. In this study,
46
results of this study demonstrated the effectiveness of the improvement in triglyceride levels over 12 weeks is
spore forming Bacilli probiotic in lowering HT in significant in that lowering of CVD risk is of importance
participants and therefore decreasing the risk for CVD due to the epidemiological data linking HT with CVD
events. events.

Campbell—Spore Forming Bacilli Supplementation for HT Integrative Medicine • Vol. 19, No. 2 • April 2020 25